Dietary intake and arsenic methylation in a U.S. population

Environmental Health Perspectives

Volumn 113, Issue 9, 2005, Pages 1153-1159

  Steinmaus, Craig ^a,b   Carrigan, Kenichi ^b   Kalman, Dave ^c   Atallah, Raja ^c   Yuan, Yan ^a   Smith, Allan H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Arsenic; Drinking water; Environmental health; Metabolism; Nutritional susceptibility

Indexed keywords

ARSENIC; IRON; NICOTINIC ACID; THIAMINE; ZINC;

ADULT; AGED; ANAMNESIS; ARTICLE; BLADDER CANCER; CANCER RISK; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; METHYLATION; PRIORITY JOURNAL; PROTEIN INTAKE; REGRESSION ANALYSIS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ARSENIC; ARSENICALS; DIET; DIETARY PROTEINS; FEMALE; HUMANS; IRON; MALE; METHYLATION; MIDDLE AGED; NIACIN; UNITED STATES; WATER POLLUTANTS, CHEMICAL; ZINC;

EID: 25844464844     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7907     Document Type: Article

References (87)

1. Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, et al. 2000. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13:693-697.
2. Ayotte JO, Montgomery DL, Flanagan SM, Robinson KW. 2003. Arsenic in groundwater in eastern New England: occurrence, controls, and human health implications. Environ Sci Technol 37:2075-2083.
3. Beck B, Boardman P, Hook G, Rudel R, Slayton T, Carlson-Lynch H. 1995. Response to Smith et al. [Letter]. Environ Health Perspect 103:15-17.
4. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. 1986. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124:453-469.
5. Block G, Woods M, Potosky A, Clifford C. 1990. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 43:1327-1335.
6. Brouwer OF, Onkenhout W, Edelbroek PM, de Kom JF, de Wolff FA, Peters AC. 1992. Increased neurotoxicity of arsenic in methylenetetrahydrofolate reductase deficiency. Clin Neurol Neurosurg 94:307-310.
7. Brown K, Beck B. 1996. Arsenic and bladder cancer mortality. Epidemiology 7:557-558.
8. Buchet JP, Lauwerys R. 1985. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch Toxicol 57:125-129.
9. Buchet JP, Lauwerys R, Roels H. 1981. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 48:71-79.
10. Calderon R, Hudgens E, Le XC, Schreinmachers D, Thomas DJ. 1999. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ Health Perspect 107:663-667.
11. Carlson-Lynch H, Beck BD, Boardman PD. 1994. Arsenic risk assessment [Letter]. Environ Health Perspect 102:354-356.
12. Chen CJ, Wu MW, Lee SS, Wang JD, Cheng SH, Wu HY. 1988. Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 8:452-460.
13. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, et al. 2003a. Arsenic methylation and skin cancer risk in southwest Taiwan. J Occup Environ Med 45:241-248.
14. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. 2003b. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14:303-310.
15. Chiou HY, Hsueh YM, Hsieh LL, Hsu LI, Hsu YH, Hsieh FI, et al. 1997. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res 386:197-207.
16. Christian W, Hopenhayn C. 2004. Is arsenic metabolism in exposed populations influenced by selenium? [Abstract]. Epidemiology 15:S107.
17. Chung JS, Kalman DA, Moore LE, Kosnett MJ, Arroyo AP, Beeris M, et al. 2002. Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water. Environ Health Perspect 110:729-733.
18. Coates R, Eley J, Block G, Gunter E, Sowell A, Grossman C, et al. 1991. An evaluation of a food frequency questionnaire for assessing dietary intake of specific carotenoids and vitamin E among low-income black women. Am J Epidemiol 134:658-671.
19. Concha G, Volger G, Nermell B, Vahter M. 2002. Intro-individual variation in the metabolism of inorganic arsenic. Int Arch Occup Environ Health 75:576-580.
20. Crecelius EA. 1978. Modification of the arsenic speciation technique using hydride generation. Anal Chem 50:826-827.
21. Cullen WR, McBride BC, Manji H, Pickett AW, Reglinski J. 1989. The metabolism of methylarsine oxide and sulfide. Appl Organometal Chem 3:71-78.
22. Del Razo L, Aguilar C, Sierra-Santoyo A, Cebrian M, Varillas A. 1999. Interference in the quantification of methylated arsenic species in human urine. J Anal Toxicol 23:103-107.
23. Del Razo LM, Garcia-Vargas GG, Vargas H, Albores A, Gonsebatt ME, Montero R, et al. 1997. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol 71:211-217.
24. Del Razo LM, Styblo M, Cullen WR, Thomas DJ. 2001. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharm 174:282-293.
25. Engel RR, Receveur O. 1993. Re: "Arsenic ingestion and internal cancers: a review" [Letter]. Am J Epidemiol 138:896-897.
26. Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. 2000. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11:673-679.
27. Gebel TW. 2002. Arsenic methylation is a process of detoxification through accelerated excretion. Int J Hyg Environ Health 205:505-508.
28. Guha Mazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakraborty D, et al. 1998. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 27:871-877.
29. Hartman A, Block G, Chan W, Williams J, McAdams M, Banks W, et al. 1996. The reproducibility of a self-administered diet history questionnaire administered three times over three different seasons. Nutr Cancer 25:305-315.
30. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, et al. 1996a. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7:117-124.
31. Hopenhayn-Rich C, Biggs ML, Smith AH. 1998. Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina. Int J Epidemiol 27:561-569.
32. Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE. 1996b. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 104:620-628.
33. Hopenhayn-Rich C, Smith AH, Goeden HM. 1993. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res 60:161-177.
34. Hsueh YM, Cheng GS, Wu MM, Yu HS, Kuo TL, Chen CJ. 1995. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer 71:109-114.
35. Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MH, et al. 1997. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev 6:589-596.
36. Hsueh YM, Ko YF, Huang YK, Chen HW, Chiou HY, Huang YL, et al. 2003. Determinants of inorganic arsenic methylation capacity among residents of the Lanyang Basin, Taiwan: arsenic and selenium exposure and alcohol consumption. Toxicol Lett 137:49-63.
37. Hughes MF, Kenyon EM. 1998. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J Toxicol Environ Health A 53:95-112.
38. Lammon C, Hood R. 2004. Effects of protein deficient diets on the developmental toxicity of inorganic arsenic in mice. Birth Defects Res B 71:124-134.
39. Le XC, Ma M, Lu X, Cullen WR, Aposhian HV, Zheng B. 2000. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 108:1015-1018.
40. Lin S, Cullen WR, Thomas DJ. 1999. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem Res Toxicol 12:924-930.
41. Lin S, Del Razo LM, Styblo M, Wang C, Cullen WR, Thomas DJ. 2001. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem Res Toxicol 14:305-311.
42. Maki-Paakkanen J, Kurttio P, Paldy A, Pekkanen J. 1998. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ Mol Mutagen 32:301-313.
43. Mandal BK, Ogra Y, Suzuki K. 2001. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14:371-378.
44. Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ, et al. 2001. Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 14:355-361.
45. Milton A, Zalewski P, Ratnaike R. 2004. Zinc protects against arsenic-induced apoptosis in a neuronal cell line, measured by DEVD-capase activity. Biometals 17:707-713.
46. Mitra S, Guha Mazumder D, Basu A, Block G, Haque R, Samanta S, et al. 2004. Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ Health Perspect 112:1104-1109.
47. Moore MM, Harrington-Brock K, Doerr CL. 1997. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat Res 386:279-290.
48. Morales K, Ryan L, Kuo T, Wu M, Chen C. 2000. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect 108:655-661.
49. Mushak P, Crocetti AF. 1995. Risk and revisionism in arsenic cancer risk assessment. Environ Health Perspect 103:684-689.
50. Mushak P, Crocetti AF. 1996. Response: accuracy, arsenic, and cancer [Letter]. Environ Health Perspect 104:1014-1015.
51. NCI. 1997. HHHQ-DIETSYS Analysis Software, version 4.01. Bethesda, MD:National Cancer Institute.
52. Nordstrom DK. 2002. Public health. Worldwide occurrences of arsenic in ground water. Science 296:2143-2145.
53. NRC. 1999. Arsenic in Drinking Water. Washington, DC:National Research Council, Subcommittee on Arsenic in Drinking Water.
54. NRC. 2001. Arsenic in Drinking Water 2001 Update. Washington, DC:National Research Council, Subcommittee to Update the 1999 Arsenic in Drinking Water Report.
55. Okoji RS, Yu RC, Maronpot RR, Froines JR. 2002. Sodium arsenite administration via drinking water increases genome-wide and Ha-ras DNA hypomethylation in methyl-deficient C57BL/6J mice. Carcinogenesis 23:777-785.
56. Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Aposhian VH. 2000. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163:203-207.
57. Poddar S, Mukherjee P, Talukder G, Sharma A. 2000. Dietary protection by iron against clastogenic effects of short-term exposure to arsenic in mice in vivo. Food Chem Toxicol 38:735-737.
58. Rabbani G, Saha S, Akhtar M, Marni F, Mitra A, Ahmed S, et al. 2003. Antioxidants in detoxification of arsenic-induced oxidative injury in rabbits: preliminary results. J Environ Sci Health A Tox Hazard Subst Environ Eng 1:273-287.
59. Shimizu M, Hochadel JF, Fulmer BA, Waalkes MP. 1998. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro. Toxicol Sci 45:204-211.
60. Slayton TM, Barbara B, Reynolds K, Chapnick S, Valberg P, Yost L, et al. 1996. Issues in arsenic cancer risk assessment. Environ Health Sciences 104:1012-1014.
61. Smith A, Lopipero P, Bates M, Steinmaus C. 2002. Arsenic epidemiology and drinking water standards. Science 296:2145-2146.
62. Smith AH, Arroyo AP, Guha-Mazumder DN, Kosnett MJ, Hernandez AL, Beeris M, et al. 2000. Arsenic-induced skin lesions among Atacameno people in Northern Chile despite good nutrition and centuries of exposure. Environ Health Perspect 108:617-620.
63. Smith AH, Goycolea M, Haque R, Biggs ML. 1998. Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water. Am J Epidemiol 147:660-669.
64. Steinmaus C, Bates M, Rey O, Yuan Y. 2004. Arsenic methylation and bladder cancer risk in case-control studies from Argentina and the United States [Abstract]. Epidemiology 15:S80-S81.
65. Steinmaus C, Yuan Y, Bates MN, Smith AH. 2003. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158:1193-1201.
66. Steinmaus C, Yuan Y, Kalman D, Atallah R, Smith A. 2005. Intraindividual variability in arsenic methylation in a US population. Cancer Epidemiol Biomarkers Prev 14:919-924.
67. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, et al. 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289-299.
68. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ. 2002. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110 (suppl 5):S767-S771.
69. Styblo M, Serves S, Cullen W, Thomas D. 1997. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem Res Toxicol 10:27-33.
70. Styblo M, Vega L, Germolec DR, Luster MI, Del Razo LM, Wang C, et al. 1999. Metabolism and toxicity of arsenicals in cultured cells. In: Arsenic: Exposure and Health Effects (Chappell WR, Abernathy CO, Calderon RL, eds). Amsterdam:Elsevier Science, 311-324.
71. Tice RR, Yager JW, Andrews P, Crecelius E. 1997. Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite. Mutat Res 386:315-334.
72. U.S. EPA (Environmental Protection Agency). 2001. National primary drinking water regulations; arsenic and clarifications to compliance and new source contaminants monitoring. Fed Reg 66:37617-37619.
73. U.S. Geological Survey. 2004. Estimated Use of Water in the United States in 2000. Denver, CO:U.S. Geological Survey. Available: http://water.usgs.gov/pubs/circ/2004/circ1268/ [accessed 10 October 2004].
74. Vahter M. 1999. Methylation of inorganic arsenic in different mammalian species and population groups. Sci Prog 82:69-88.
75. Vahter M. 2000. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 112-113:209-217.
76. Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology 181:211-217.
77. Vahter M, Marafante E. 1987. Effects of low dietary intake of methionine, choline, and proteins of the biotransformation of arsenite in the rabbit. Toxicol Lett 37:41-46.
78. Valenzuela O, Borja-Aburto V, Garcia-Vargas G, et al. 2005. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect 113:250-254.
79. Wang CT. 1996. Concentration of arsenic, selenium, zinc, iron and copper in the urine of blackfoot disease patients at different clinical stages. Eur J Clin Chem Clin Biochem 34:493-497.
80. Wang Z, Zhou J, Lu X, Gong Z, Le C. 2004. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Chem Res Toxicol 17:95-103.
81. Weinshilboum R. 1988. Pharmacogenetics of methylation: relationship to drug metabolism. Clin Biochem 21:201-210.
82. Weinshilboum RM. 1992. Methylation pharmacogenetics: thiopurine methyltransferase as a model system. Xenobiotica 22:1055-1071.
83. Welch AH, Helsel DR, Focazio MJ, Watkins SA. 1999. Arsenic in ground water supplies of the United States. In: Arsenic Exposure and Health Effects: Proceedings of the Third International Conference on Arsenic Exposure and Health Effects, July 12-15, 1998, San Diego, California (Chappell WR, Abernathy CO, Calderon RL, eds). New York:Elsevier Science, 9-17.
84. Willett W, Stampfer M. 1998. Implications of total energy intake for epidemiologic analysis. In: Nutritional Epidemiology (Willet W, ed). 2nd ed. New York:Oxford University Press, 273-301.
85. Yang T, Blackwell R. 1961. Nutritional and environmental conditions in the blackfoot area. Formosan Sci 15:101-129.
86. Yu RC, Hsu KH, Chen CJ, Froines JR. 2000. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 9:1259-1262.
87. Zhuo H, Smith AH, Steinmaus C. 2004. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev 13:771-778.